ArticleRSC advances2021

Newly designed analogues from SARS-CoV inhibitors mimicking the druggable properties against SARS-CoV-2 and its novel variants.

Nadim Ferdous et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.